AI Article Synopsis

  • The study examined how cyclophosphamide affects the phagocytosis activity of macrophages from mice.
  • Mice treated with cyclophosphamide showed increased phagocytic activity when tested without serum or with decomplemented serum.
  • The results suggest that low doses of cyclophosphamide don't impact macrophage function significantly, but it may inhibit other immune cells like T and B lymphocytes.

Article Abstract

The action of cyclophosphamide on phagocytosis by macrophages from mouse peritoneal exudate cultured in vitro was studied. The mice were pretreated with cyclophosphamide administered for seven days. The experiments were carried out in the presence of serum (with or without complement) from untreated animals or without serum. A significantly increased phagocytic activity was shown in experiments without serum and when decomplemented serum was used. No significant variation was found when macrophages from treated mice were tested with serum with complement from untreated animals. It is tentatively assumed that low dosage administration in vivo of cyclophosphamide does not affect macrophage phagocytic activity while several findings suggest an inhibitory effect of cyclophosphamide on T and B lymphocytes.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02905880DOI Listing

Publication Analysis

Top Keywords

phagocytic activity
12
serum complement
8
complement untreated
8
untreated animals
8
cyclophosphamide
5
serum
5
influence vivo
4
vivo pretreatment
4
pretreatment cyclophosphamide
4
cyclophosphamide phagocytic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!